Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May;19(5):787-90.
doi: 10.1128/CVI.05724-11. Epub 2012 Mar 21.

Microbiological challenges in the diagnosis of chronic Q fever

Affiliations

Microbiological challenges in the diagnosis of chronic Q fever

Linda M Kampschreur et al. Clin Vaccine Immunol. 2012 May.

Abstract

Diagnosis of chronic Q fever is difficult. PCR and culture lack sensitivity; hence, diagnosis relies mainly on serologic tests using an immunofluorescence assay (IFA). Optimal phase I IgG cutoff titers are debated but are estimated to be between 1:800 and 1:1,600. In patients with proven, probable, or possible chronic Q fever, we studied phase I IgG antibody titers at the time of positive blood PCR, at diagnosis, and at peak levels during chronic Q fever. We evaluated 200 patients, of whom 93 (46.5%) had proven, 51 (25.5%) had probable, and 56 (28.0%) had possible chronic Q fever. Sixty-five percent of proven cases had positive Coxiella burnetii PCR results for blood, which was associated with high phase I IgG. Median phase I IgG titers at diagnosis and peak titers in patients with proven chronic Q fever were significantly higher than those for patients with probable and possible chronic Q fever. The positive predictive values for proven chronic Q fever, compared to possible chronic Q fever, at titers 1:1,024, 1:2,048, 1:4,096, and ≥1:8,192 were 62.2%, 66.7%, 76.5%, and ≥86.2%, respectively. However, sensitivity dropped to <60% when cutoff titers of ≥1:8,192 were used. Although our study demonstrated a strong association between high phase I IgG titers and proven chronic Q fever, increasing the current diagnostic phase I IgG cutoff to >1:1,024 is not recommended due to increased false-negative findings (sensitivity < 60%) and the high morbidity and mortality of untreated chronic Q fever. Our study emphasizes that serologic results are not diagnostic on their own but should always be interpreted in combination with clinical parameters.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Phase I IgG titers at the time of C. burnetii PCR-positive (n = 62) and -negative (n = 25) findings for blood (plasma or serum) of proven chronic Q fever cases. PCR-positive patients include patients with PCR-positive findings in blood with or without positive tissue PCR; PCR-negative patients include patients with negative PCR findings in blood with or without positive tissue PCR results. Logistic regression analysis demonstrated a significant rise in the probability of positive PCR in case of increasing phase I IgG titers using a binary dilution scale (odds ratio [OR], 1.35; 95% confidence interval, 1.02 to 1.77; P = 0.033).
Fig 2
Fig 2
Box plot demonstrating the distribution of titers of IgG antibodies against Coxiella burnetii phase I antigens (phase I IgG) at the time of diagnosis and at the time of peak titers in proven, probable, and possible Q fever cases. The black bars indicate the median IgG titers. Titers on the y axis are represented on a binary scale. Median phase I IgG titers were significantly higher for proven chronic Q fever cases (P < 0.05).
Fig 3
Fig 3
Receiver operator characteristics (ROC) curve of titers of IgG antibodies against Coxiella burnetii phase I antigens at the time of diagnosis and peak titers to differentiate between proven and possible chronic Q fever. The AUC was 0.78 (95% CI, 0.70 to 0.85) for phase I IgG titers the at time of diagnosis and 0.79 (95% CI, 0.72 to 0.86) for phase I IgG peak titers.

References

    1. Botelho-Nevers E, et al. 2007. Coxiella burnetii infection of aortic aneurysms or vascular grafts: report of 30 new cases and evaluation of outcome. Eur. J. Clin. Microbiol. Infect. Dis. 26:635–640 - PubMed
    1. Delsing CE, Kullberg BJ, Bleeker-Rovers CP. 2010. Q fever in the Netherlands from 2007 to 2010. Neth. J. Med. 68:382–387 - PubMed
    1. Dupont HT, Thirion X, Raoult D. 1994. Q fever serology: cutoff determination for microimmunofluorescence. Clin. Diagn. Lab. Immunol. 1:189–196 - PMC - PubMed
    1. Fenollar F, et al. 2001. Risks factors and prevention of Q fever endocarditis. Clin. Infect. Dis. 33:312–316 - PubMed
    1. Fenollar F, Fournier PE, Raoult D. 2004. Molecular detection of Coxiella burnetii in the sera of patients with Q fever endocarditis or vascular infection. J. Clin. Microbiol. 42:4919–4924 - PMC - PubMed

Publication types

LinkOut - more resources